Production (Stage)
NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.96% | -0.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.96% | -0.23% | |||
| Operating Income | 11.96% | 0.23% | |||
| Income Before Tax | -123.86% | 1,076.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -123.86% | 1,076.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -123.86% | 1,076.98% | |||
| EBIT | 11.96% | 0.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -123.93% | 1,068.29% | |||
| Normalized Basic EPS | -1.72% | -132.00% | |||
| EPS Diluted | -123.93% | 1,068.29% | |||
| Normalized Diluted EPS | -1.72% | -132.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||